| OMNICELL INC. DL-,001 |
| USA |
| Gesundheit |
| US68213N1090 / 632313 |
| OC9 (Frankfurt) / OMCL (NASDAQ) |
| FRA:OC9, ETR:OC9, OC9:GR, NASDAQ:OMCL |
| - |
| https://www.omnicell.com/ |
|
Omnicell Inc. operates as a provider of medication..
>Volltext.. |
| 1850.01 Mio. EUR |
| 1834.14 Mio. EUR |
| 996.96 Mio. EUR |
| 89.37 Mio. EUR |
| 16.86 Mio. EUR |
| 0.37 EUR |
| 175.04 Mio. EUR |
| 190.85 Mio. EUR |
| 129.74 Mio. EUR |
| 0.49 |
| 5.01% |
| - |
| - |
| - |
| - |
| OMNICELL |
| 05.02.26 |
|
||||
|